Showing results (81-90 of 106) with videos related to
Sort By:
Pageof 11
Research and Practice in Thrombosis and Haemostasis|August 29, 2022
A systematic review of biomarkers among hospitalized patients with COVID-19 predictive of venous thromboembolism: A communication from the Predictive and Diagnostic Variables Scientific and Standardization Committee of the ISTHScott C Woller, Kerstin de Wit, Helia Robert-Ebadi, et al.Annals of Internal Medicine|June 16, 2004
Withholding anticoagulation after a negative result on duplex ultrasonography for suspected symptomatic deep venous thrombosisScott M Stevens, C Gregory Elliott, Karen J Chan, et al.Journal of Thrombosis and Haemostasis : JTH|September 4, 2020
Use of direct oral anticoagulants in patients with thrombotic antiphospholipid syndrome: Guidance from the Scientific and Standardization Committee of the International Society on Thrombosis and HaemostasisStéphane Zuily, Hannah Cohen, David Isenberg, et al.Journal of the American Geriatrics Society|July 22, 2008
Resident-to-resident aggression in long-term care facilities: insights from focus groups of nursing home residents and staffTony Rosen, Mark S Lachs, Ashok J Bharucha, et al.Journal of Thrombosis and Haemostasis : JTH|July 2, 2023
Use of patient-reported outcome measures in patients with venous thromboembolism: communication from the ISTH SSC Subcommittee on Predictive and Diagnostic Variables in Thrombotic DiseaseCindy M M de Jong, Kerstin de Wit, Stephen A Black, et al.JAMA|October 4, 2017
Effect of Genotype-Guided Warfarin Dosing on Clinical Events and Anticoagulation Control Among Patients Undergoing Hip or Knee Arthroplasty: The GIFT Randomized Clinical TrialBrian F Gage, Anne R Bass, Hannah Lin, et al.JAMA|September 4, 2019
Effect of Low-Intensity vs Standard-Intensity Warfarin Prophylaxis on Venous Thromboembolism or Death Among Patients Undergoing Hip or Knee Arthroplasty: A Randomized Clinical TrialBrian F Gage, Anne R Bass, Hannah Lin, et al.Journal of Thrombosis and Haemostasis : JTH|June 23, 2022
Management of bleeding risk in patients who receive anticoagulant therapy for venous thromboembolism: Communication from the ISTH SSC Subcommittee on Predictive and Diagnostic Variables in Thrombotic DiseasePaul L den Exter, Scott C Woller, Helia Robert-Ebadi, et al.Lupus|October 26, 2020
16th International Congress on Antiphospholipid Antibodies Task Force Report on Antiphospholipid Syndrome Treatment TrendsHannah Cohen, Maria J Cuadrado, Doruk Erkan, et al.Journal of Health Care for the Poor and Underserved|June 7, 2005
It takes a village: a multidisciplinary model for the acute illness aftercare of individuals experiencing homelessnessAdi Gundlapalli, Monte Hanks, Scott M Stevens, et al.Pageof 11